 |
|
|
|
Year 2019 - Volume 39, Number 2
|
|
Sedative and electrocardiographic effects of low dose dexmedetomidine in healthy cats, 39(2):142-147
|
ABSTRACT.- Carvalho E.R, Champion T., Vilani R.G.O.C., Freitas G.C., Ambrosini F., Silva G.A., Gonçalves K.S. & Fischborn J.C.J. 2019. Sedative and electrocardiographic effects of low dose dexmedetomidine in healthy cats. Pesquisa Veterinária Brasileira 39(2):142-171. Universidade Federal da Fronteira Sul, Rodovia BR-182 Km 466, Avenida Edmundo Gaievski 1000, Cx. Postal 253, Realeza, PR 85770-000, Brazil. E-mail: beth_rcarvalho@hotmail.com
In feline veterinary practice sedation is often needed to perform diagnostic or minimally invasive procedures, minimize stress, and facilitate handling. The mortality rate of cats undergoing sedation is significantly higher than dogs, so it is fundamental that the sedatives provide good cardiovascular stability. Dexmedetomidine (DEX) is an α2-adrenergic receptor agonist utilized in cats to provide sedation and analgesia, although studies have been utilized high doses, and markedly hemodynamic impairments were reported. The aim of this study was to prospectively investigate how the sedative and electrocardiographic effects of a low dose of DEX performing in cats. Eleven healthy cats were recruited; baseline sedative score, systolic arterial pressure, electrocardiography, and vasovagal tonus index (VVTI) were assessed, and repeated after ten minutes of DEX 5µg/kg intramuscularly (IM). A smooth sedation was noticed, and emesis and sialorrhea were common adverse effects, observed on average seven minutes after IM injection. Furthermore, electrocardiographic effects of a low dose of DEX mainly include decreases on heart rate, and increases on T-wave amplitude. The augmentation on VVTI and appearance of respiratory sinus arrhythmia, as well as sinus bradycardia in some cats, suggesting that DEX enhances parasympathetic tonus in healthy cats, and therefore will be best avoid in patients at risk for bradycardia. |
| |
|
|
| |
|
|
